PANACEABIO.BOPANACEABIO.BOBSE
Loading
Operating Expenses Over TimeContracting
Percentile Rank40
3Y CAGR+25.9%
5Y CAGR+27.1%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+25.9%/yr
vs -7.3%/yr prior
5Y CAGR
+27.1%/yr
Consistent
Acceleration
+33.1pp
Accelerating
Percentile
P40
Within normal range
vs 5Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$3.68B-12.4%
2025$4.20B+618.9%
2024$584.62M-68.3%
2023$1.85B-53.1%
2022$3.93B+254.0%
2021$1.11B-36.7%
2020$1.76B-29.6%
2019$2.50B-31.2%
2018$3.63B-11.6%
2017$4.11B-